Tesamorelin 10mg – Growth Hormone Releasing Hormone (GHRH) Research Support
 
Tesamorelin is a high-purity, synthetic peptide analog of Growth Hormone Releasing Factor (GRF). It is composed of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group, which provides increased stability and resistance to enzymatic degradation for advanced laboratory research.
 
Tesamorelin is extensively studied in experimental models for its potent influence on growth hormone (GH) secretion and lipid metabolism. Researchers investigate its ability to selectively stimulate the pituitary gland, leading to the endogenous release of GH without disrupting other endocrine pathways. In laboratory settings, it is primarily researched for its role in reducing visceral adipose tissue (VAT) and modulating hepatic fat content. Its biochemical mechanism involves binding to and activating GHRH receptors, making it a critical subject for studies involving metabolic syndrome, glucose homeostasis, and the regulation of body composition.
 
This advanced research-grade peptide is frequently utilized in laboratory settings to analyze the interaction between growth hormone signaling and lipid partitioning, as well as the maintenance of metabolic health and cellular homeostasis.
 
High purity: 99% HPLC
CAS#: 218949-48-5
Molecular Weight: 5135.76 g/mol
Chemical Formula: $C_{221}H_{366}N_{72}O_{67}S$
 
For laboratory research use only. Not for human or veterinary consumption.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.